AFX-2

N/A

Report date: 2023/01/14 16:58:40
NME

Base Information

Drug NameAFX-2
Drug Alias NameCOLD-fXCVT-E002AFX-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsRhinitis, Allergic, SeasonalLeukemia, Lymphocytic, Chronic, B-CellRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBausch Health Companies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCv TechnologiesAfexa Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, SeasonalLeukemia, Lymphocytic, Chronic, B-CellRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksWikipedia